Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ACARICIDAL SYNTHETIC MATERIALS AND ARTICLES MADE THEREFROM
Document Type and Number:
WIPO Patent Application WO/2008/046746
Kind Code:
A2
Abstract:
Synthetic thermoplastic polymer articles are effectively protected from infestation by mites such as house dust mites or bedmites, by incorporation of an agent selected from Propiconazole, Cyproconazole, Difenoconazole, Fludioxonil, Thiabendazole, Tebuconazole, Zinc Pyrithione, 2-n-Octyl-4-isothiazolin-3-on, 4,5-Di-chlor-N-n-octyl-isothiazolin-3-on, certain 2,4-bis(alkylamino)pyrimidines or silvers as given in claim 1, Carbendazim, 10,10'-oxy-bis- phenoxyarsene, and/or n-butyl-1,2-benzisothiazolin-3-on and optionally an antimicrobial agent into the bulk of the resin. Final articles may be filters, bed clothes and fillings, mattresses, covers, pillowcases, upholstery fabrics and foams, textiles, and floor coverings including carpets, backing material like backing for flooring, underlays.

Inventors:
SCHNEIDER, Armin (Lehenerstrasse 59, Freiburg, 79106, DE)
HERBST, Heinz (Friedrichstrasse 2, Lörrach, 79541, DE)
RIEFFEL, Thi, Thoa (3 rue des Sapins, Muespach, F-68640, FR)
KOLB, Markus (Waldeckstrasse 14, Kandern, 79400, DE)
Application Number:
EP2007/060576
Publication Date:
April 24, 2008
Filing Date:
October 05, 2007
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
CIBA HOLDING INC. (Klybeckstrasse 141, Basel, CH-4057, CH)
SCHNEIDER, Armin (Lehenerstrasse 59, Freiburg, 79106, DE)
HERBST, Heinz (Friedrichstrasse 2, Lörrach, 79541, DE)
RIEFFEL, Thi, Thoa (3 rue des Sapins, Muespach, F-68640, FR)
KOLB, Markus (Waldeckstrasse 14, Kandern, 79400, DE)
International Classes:
A01N25/10; A01N25/34; A01N43/36; A01N43/40; A01N43/653; A01N43/78; A01N43/80; A01N59/16; A01P7/02; A47G9/00; D01F1/00; D06M16/00
Domestic Patent References:
WO1999021421A11999-05-06
WO2005089552A12005-09-29
WO2004094120A12004-11-04
WO2006006594A12006-01-19
WO2007042416A12007-04-19
Foreign References:
JPH05148109A1993-06-15
KR20040083050A2004-09-30
JPH08169981A1996-07-02
EP0732052A21996-09-18
Other References:
DATABASE WPI Week 199402 Thomson Scientific, London, GB; AN 1994-011756 XP002512676 -& JP 05 318635 A (KIDA H) 3 December 1993 (1993-12-03)
DATABASE WPI Week 198922 Thomson Scientific, London, GB; AN 1989-162036 XP002512802 & JP 01 104821 A (UBE NITTO KASEI CO) 21 April 1989 (1989-04-21)
Attorney, Agent or Firm:
CIBA HOLDING INC. (Patent Department, Klybeckstrasse 141, Basel, CH-4057, CH)
Download PDF:
Claims:

Claims:

1. Method for reducing infestation of an article by mites, especially house dust mites or bedmites, which method comprises incorporation of a synthetic thermoplastic polymer resin containing an agent selected from Thiabendazole, metallic silver, silver-glass, silver zeolite, Propiconazole, Cyproconazole, Difenoconazole, Tebuconazole, Fludioxonil, Zinc Pyrithione, 2-n-Octyl-4-isothiazolin-3-on, 4,5-Di-chlor-N-n-octyl-isothiazolin-3-on, n-butyl-1 ,2- benzisothiazolin-3-on, 2,4-bis(alkylamino)pyrimidines of the formulae

Carbendazim, 10,10'-oxy-bis-phenoxyarsene, or mixtures thereof, in the bulk of said polymer resin, into the surface of the article.

2. Method of claim 1 , wherein the article is a household article or garment or industrial article, especially selected from filters, bed clothes and fillings, mattresses, covers, pillowcases, upholstery fabrics and foams, textiles, and floor coverings including carpets, backing material like backing for flooring, underlays.

3. Method of claim 1 , wherein the polymer resin has the form of a molding, film, tape, monofilament, fiber, fabric, nonwoven, foam, profile, adhesive or putty, surface coating.

4. Method of claim 1 , wherein the resin contains a second agent, which is preferably selected from phenolic antimicrobial compounds of the formula (I)

wherein n is 0 or preferably 1 , Ri and R 2 are hydrogen or chloro,

R 3 is hydroxyl or preferably hydrogen,

R 4 , R5 and R 6 are hydrogen or chloro,

R 7 is hydroxyl, and

X is a direct bond, -NHCONH-, -CH 2 - or preferably -O-; and/or silver, silver complexes and silver salts.

5. Method of claim 4, wherein the first agent of claim 1 selected from the group consisting of Thiabendazol, Tebuconazol, Zinc Pyrithione, 2-n-Octyl-4-isothiazolin-3-on, 4,5-Di-chlor-N-n- octyl-isothiazolin-3-on, 2,4-bis(alkylamino)pyrimidines of formula lib, Nc, Nd, Propiconazole, Cyproconazole, Difenoconazole, Fludioxonil is combined with the second agent of claim 4 especially selected from the group consisting of 2-phenylphenol, 2,4,4'-trichloro-2'-hydroxy- diphenylether, 4,4'-dichloro-2-hydroxydiphenylether, 2,2'-methylene-bis-(4-chloro-phenol), 4- (2-t-butyl-5-methylphenoxy)-phenol, 3-(4-chlorophenyl)-1 -(3,4-dichloro-phenyl)-urea, 2,4,6- trichlorophenol, AgCI, AgNO 3 , Ag 2 SO 4 , silver-zeolites, silver-glass, silver-zirconates, metallic

silver such as silver dispersed in white oil; or the first agent is selected from the group consisting of metallic silver, silver zeolite and silver-glass, and is combined with Thiabendazole and/or the phenolic antimicrobial compounds of the formula (I) especially selected from the group consisting of 2-phenylphenol, 2,4,4'-trichloro-2'-hydroxy- diphenylether, 4,4'-dichloro-2-hydroxydiphenylether, 2,2'-methylene-bis-(4-chloro-phenol), 4- (2-t-butyl-5-methylphenoxy)-phenol, 3-(4-chlorophenyl)-1 -(3,4-dichloro-phenyl)-urea, 2,4,6- trichlorophenol.

6. Method of claim 1 , wherein the synthetic thermoplastic polymer resin is selected from polyethylene, polypropylene, ethylene vinylacetate, polyesters such as PET or PET-G or PLA, polyol, polyoxymethylene, thermoplastic polyolefin, polyurethane, thermoplastic polyurethane, polyvinylchloride, polyamide, or corresponding blends.

7. Process for the preparation of an acaricide material, characterized in that an agent selected from Thiabendazole, metallic silver, silver-glass, silver zeolite, Propiconazole, Cyproconazole, Difenoconazole, Fludioxonil, Tebuconazole, Zinc Pyrithione, 2-n-Octyl-4- isothiazolin-3-on, 4,5-Di-chlor-N-n-octyl-isothiazolin-3-on, 2,4-bis(alkylamino)pyrimidines of the formulae

(lie)

and Carbendazim, 10,10'-oxy-bis-phenoxyarsene, n-butyl-1 ,2-benzisothiazolin-3-on, and mixtures thereof, and optionally an antimicrobial second agent is incorporated into the bulk of a synthetic thermoplastic polymer resin, which makes up the acaricide material or is incorporated into the surface of the acaricide material.

8. Process of claim 7, wherein the first agent and optional second agent is mixed with the polymer resin in plastic state with application of heat, preferably as a masterbatch or as melt additive, before its shaping into a molding, film, tape, mono-filament, fiber, fabric, nonwoven, foam, profile, adhesive, putty, surface coating.

9. Method according to any of claims 1-6, or process of claim 7, wherein the first agent is contained in the polymer resin in an amount from 0.01 % to 10 % by weight of the resin, and the second agent, if present, is contained in the ratio first : second agent (weight:weight) from 0.5 : 20 to 20 : 0.5.

10. Use of a synthetic thermoplastic polymer resin containing an agent as defined in claim 1 , and optionally a second agent such as defined in claim 4, in the bulk of the resin for the preparation of an acaricide material or article.

1 1. Acaricide fabric, foam, textile, carpet, film, tape, mono-filament, fiber, nonwoven, adhesive or putty, which comprises a synthetic thermoplastic polymer resin containing an agent as defined in claim 1 , and optionally a second agent such as defined in claim 4, in the bulk of the resin.

Description:

Acaricide Synthetic Materials and Articles made therefrom

The invention pertains to a method for reducing infestation of an article, such as a household article or garment or industrial article, by mites using a synthetic thermoplastic resin which contains a specific acaricidal first agent and optionally an antimicrobial second agent incorporated in the bulk resin; to a process for the production of such a resin, to the use of said resin for imparting acaricide properties to an article, and to acaricide articles containing said resin.

Dust mites are microscopic spiders, which may proliferate in fabrics and fillings (e.g pillows, bed clothes etc), carpets, and filters as long as sufficient heat, moisture and nutrient is available. More than 80% of mites present in house dust develop in the filling of bed linen. They produce strong allergenes: Dust mite allergy shows similar symptoms to hay fever, the allergenes are now recognized as one of the main triggers for asthma and eczema.

Known methods for reducing infestation with dust mites include treatment of the surface of articles such as fibers, fabrics, carpets etc. with certain insecticides and/or fungicides or inclusion of such components in cavities of a corresponding fiber. While these methods require repeated treatment of the surfaces or more complex processes for the shaping of the articles, incorporation of an acaricide agent into the bulk polymer material of the article within the shaping process, e.g. during solution spinning as proposed in WO 99/21421 , may lead to a long lasting effect.

There is further need for a material which combines a durable effect against mite with good material properties. A further result of an effective incorporation of a suitable agent into the bulk material can be the reduction of peak concentrations on the surface and thus the reduction of a potential toxicity or allergy risk by an antimicrobial agent. For the desired result, it is of importance that properties of polymer matrix (e.g. mechanical stability, colour, surface properties) and acaricide agent (e.g. good acaricide action, stability under processing conditions) are retained.

It has now been found that an especially effective reduction of the mite population in contact with a synthethic thermoplastic polymer material may be achieved by incorporation of an agent selected from

Propiconazole, Cyproconazole, Difenoconazole, Fludioxonil, Thiabendazole, Tebuconazole, Zinc Pyrithione, 2-n-Octyl-4-isothiazolin-3-on, 4,5-Di-chlor-N-n-octyl-isothiazolin-3-on, 2,4- bis(alkylamino)pyrimidines of the formulae

and Carbendazim, 10,10'-oxy-bis-phenoxyarsene, n-butyl-1 ,2-benzisothiazolin-3-on into the polymer resin.

The acaricide effect becomes manifest in the efficient reduction or elemination of mite population on the surface of an article containing the present acaricide agent. Naturally, this surface may be an external surface, like the surface of a sheet or fiber, or an internal surface, like the surface of an open volume within a foam, or within a yarn, fabric or garment.

Also of interest as acaricide agent is elemental silver or silver glass or silver zeolite, e.g. in the form of microparticles or nanoparticles, which may (especially the microparticles) be used as such or as a dispersion in a suitable liquid such as silicone oils (e.g. polymethyldisiloxane) or white oil.

More preferred agents are Thiabendazol, Tebuconazol, Zinc Pyrithione, 2-n-Octyl-4- isothiazolin-3-on, 4,5-Di-chlor-N-n-octyl-isothiazolin-3-on, 2,4-bis(alkylamino)pyrimidines of formula lib, Nc, Nd, Propiconazole, Cyproconazole, Difenoconazole, Fludioxonil; especially Thiabendazol, Tebuconazol, Zinc Pyrithione, 2,4-bis(alkylamino)pyrimidines of formula lib, Nc, Nd), Propiconazole, Cyproconazole, Difenoconazole, Fludioxonil.

Also preferred agents are elemental silver or silver glass or silver zeolite.

The most preferred agent Thiabendazol (IUPAC name: 2-(1 ,3-thiazol-4-yl)-1 H-

benzimidazole) is a compound of the formula:

Especially good results are achievable by addition of a further (second) antimicrobial agent, which is preferably selected from phenolic antimicrobial compounds of the formula (I)

wherein n is 0 or preferably 1 ,

Ri and R 2 are hydrogen or chloro,

R 3 is hydroxyl or preferably hydrogen,

R 4 , R5 and R 6 are hydrogen or chloro,

R 7 is hydroxyl, and

- A -

X is a direct bond, -NHCONH-, -CH 2 - or preferably -0-; and/or silver or a silver complexes or salts.

Preferred examples for the antimicrobial component include

2-phenylphenol, 2.4.4'-trichloro-2'-hydroxy-diphenylether, 4,4'-dichloro-2-hydroxy- diphenylether, 2,2'-methylene-bis-(4-chloro-phenol), 4-(2-t-butyl-5-methylphenoxy)-phenol, 3- (4-chlorophenyl)-1-(3,4-dichloro-phenyl)-urea, 2,4,6-trichlorophenol, AgCI, AgNO 3 , Ag 2 SO 4 , silver-zeolites, silver-glass, silver-zirconates, silver dispersed in white oil. More preferred are 2.4.4'-trichloro-2'-hydroxy-diphenylether, 4,4'-dichloro-2-hydroxy-diphenylether, 2,2'- methylene-bis-(4-chloro-phenol), 3-(4-chlorophenyl)-1 -(3,4-dichloro-phenyl)-urea, AgCI, silver-zeolites, silver-glass, silver-zirconates, silver dispersed in white oil; especially 2,4,4'- trichloro-2'-hydroxy-diphenylether (Triclosan), silver-zeolites, silver-glass, silver-zirconates, silver dispersed in white oil.

The silver containing zeolites may be those described in U.S. Patent Nos. 4,775,585, 4,911 ,898, 4,91 1 ,899 and 6,071 ,542, the disclosures of which are hereby incorporated by reference. A zeolite is generally alumosilicate having a three dimensionally grown skeleton structure and is generally represented by xM 2/n O-AI 2 O 3 -ySiO 2 -zH 2 O, written with AI 2 O 3 as a basis, wherein M represents an ion-exchangeable metal ion, which is usually the ion of a monovalent or divalent metal; n corresponds to the valence of the metal; x is a coefficient of the metal oxide; y is a coefficient of silica; and z is the number of water of crystallization. The zeolites of the present invention have a specific surface area of at least 150m 2 /g.

Single compounds or mixtures of each component may be used. For example, using a combination of a phenolic antibacterial and a silver component as recited above may provide further advantages. Of course, one or more further components may be added selected from zinc oxide, copper and copper compounds. Silver in general includes colloidal silver, silver nitrate, silver sulphate, silver chloride, silver complexes, metal-containing zeolites and surface-modified metal-containing zeolites.

In the present materials (i.e. the article containing the synthetic polymer resin, and the polymer resin itself), the first and, if present, second agent are preferably contained in the ratio (weight/weight) from 0.5 / 20 to 20 / 0.5, especially in a ratio from 1 : 10 to 10 : 1.

The total amount of the first agent, especially the amount of first and second agent, if present, each often is in the range from 0.01 % to 10 %, especially 0.02 % to 5 %, by weight of the final material.

In many cases, a total amount of first agent or first and second agent of 0.02 % to 5 % by weight of the final material is used.

The final material (i.e. the article containing the synthetic polymer resin, which is equipped with the present agent(s), or a material for the production of such an article, e.g. the yarn for the production of a carpet) usually contains about 1-100 %, often 10-100%, especially 30- 100% b.w. of the acaricide resin. The exact amount of agent contained in the resin is often determined by the percentage of resin used in the final article or on its surface; for a good anti-mite effect, the amount of agent in the polymer resin usually is higher, if the article contains only a minor amount of the acaricide resin, and smaller, if the final article contains high amounts of the acaricide resin or consists thereof.

The present agents as well as the polymer resins containing them combine good long-term activity and a good toxicological profile with good compatibility in the polymer substrate and further components thereof (such as pigments or other colorants) and good use properties of the polymer resin.

The acaricide agent(s) of the invention may be incorporated into a plastic resin prior to its being manufacturing process such as rotational molding, fiber spinning, etc. The agent is able to withstand demanding processing conditions such as high temperature, e.g. temperatures greater than 200 0 C.

Consequently, the invention also pertains to a process for the preparation of an acaricide material, characterized in that a first agent as defined above, and optionally a further antibacterial (second) agent, is incorporated therein, as well as to the use of an agent as defined above, and optionally a further antibacterial agent, in the bulk of a synthetic polymer for reducing the infestation by mite, e.g. after addition as a melt additive during the production of the acaricide material.

Examples for the polymers, especially synthetic thermoplastic polymers, which may be equipped with the present acaricide agent are:

1. Polymers of monoolefins and diolefins, for example polypropylene, polyisobutylene, po- lybut-1-ene, poly-4-methylpent-1-ene, polyvinylcyclohexane, polyisoprene or polybutadiene, as well as polymers of cycloolefins, for instance of cyclopentene or norbornene, polyethylene

(which optionally can be crosslinked), for example high density polyethylene (HDPE), high density and high molecular weight polyethylene (HDPE-HMW), high density and ultrahigh molecular weight polyethylene (HDPE-UHMW), medium density polyethylene (MDPE), low density polyethylene (LDPE), linear low density polyethylene (LLDPE), (VLDPE) and

(ULDPE).

Polyolefins, i.e. the polymers of monoolefins exemplified in the preceding paragraph, preferably polyethylene and polypropylene, can be prepared by different, and especially by the following, methods:

a) radical polymerisation (normally under high pressure and at elevated temperature).

b) catalytic polymerisation using a catalyst that normally contains one or more than one metal of groups IVb, Vb, VIb or VIII of the Periodic Table. These metals usually have one or more than one ligand, typically oxides, halides, alcoholates, esters, ethers, amines, alkyls, alkenyls and/or aryls that may be either π- or σ-coordinated. These metal complexes may be in the free form or fixed on substrates, typically on activated magnesium chloride, titanium(lll) chloride, alumina or silicon oxide. These catalysts may be soluble or insoluble in the polymerisation medium. The catalysts can be used by themselves in the polymerisation or further activators may be used, typically metal alkyls, metal hydrides, metal alkyl halides, metal alkyl oxides or metal alkyloxanes, said metals being elements of groups Ia, Na and/or Ilia of the Periodic Table. The activators may be modified conveniently with further ester, ether, amine or silyl ether groups. These catalyst systems are usually termed Phillips, Standard

Oil Indiana, Ziegler (-Natta), TNZ (DuPont), metallocene or single site catalysts (SSC).

2. Mixtures of the polymers mentioned under 1 ), for example mixtures of polypropylene with polyisobutylene, polypropylene with polyethylene (for example PP/HDPE, PP/LDPE) and mixtures of different types of polyethylene (for example LDPE/HDPE).

3. Copolymers of monoolefins and diolefins with each other or with other vinyl monomers, for example ethylene/propylene copolymers, linear low density polyethylene (LLDPE) and mixtures thereof with low density polyethylene (LDPE), propylene/but-1-ene copolymers, propylene/isobutylene copolymers, ethylene/but-1-ene copolymers, ethylene/hexene copolymers, ethylene/methylpentene copolymers, ethylene/heptene copolymers, ethylene/octene copolymers, ethylene/vinylcyclohexane copolymers, ethylene/cycloolefin copolymers (e.g. ethylene/norbornene like COC), ethylene/1 -olefins copolymers, where the 1 -olefin is generated in-situ; propylene/butadiene copolymers, isobutylene/isoprene copolymers, ethylene/vi- nylcyclohexene copolymers, ethylene/alkyl acrylate copolymers, ethylene/alkyl methacrylate copolymers, ethylene/vinyl acetate copolymers or ethylene/acrylic acid copolymers and their salts (ionomers) as well as terpolymers of ethylene with propylene and a diene such as hexadiene, dicyclopentadiene or ethylidene-norbornene; and mixtures of such copolymers with one another and with polymers mentioned in 1 ) above, for example polypropylene/ethy- lene-propylene copolymers, LDPE/ethylene-vinyl acetate copolymers (EVA), LDPE/ethylene- acrylic acid copolymers (EAA), LLDPE/EVA, LLDPE/EAA and alternating or random polyal- kylene/carbon monoxide copolymers and mixtures thereof with other polymers, for example polyamides.

4. Hydrocarbon resins (for example C 5 -Cg) including hydrogenated modifications thereof (e.g. tackifiers) and mixtures of polyalkylenes and starch.

Homopolymers and copolymers from 1.) - 4.) may have any stereostructure including syndio- tactic, isotactic, hemi-isotactic or atactic; where atactic polymers are preferred. Stereoblock polymers are also included.

5. Polystyrene, poly(p-methylstyrene), poly(α-methylstyrene).

6. Aromatic homopolymers and copolymers derived from vinyl aromatic monomers including styrene, α-methylstyrene, all isomers of vinyl toluene, especially p-vinyltoluene, all isomers of ethyl styrene, propyl styrene, vinyl biphenyl, vinyl naphthalene, and vinyl anthracene, and

mixtures thereof. Homopolymers and copolymers may have any stereostructure including syndiotactic, isotactic, hemi-isotactic or atactic; where atactic polymers are preferred. Ste- reoblock polymers are also included.

6a. Copolymers including aforementioned vinyl aromatic monomers and comonomers selected from ethylene, propylene, dienes, nitriles, acids, maleic anhydrides, maleimides, vinyl acetate and vinyl chloride or acrylic derivatives and mixtures thereof, for example styrene/bu- tadiene, styrene/acrylonitrile, styrene/ethylene (interpolymers), styrene/alkyl methacrylate, styrene/butadiene/alkyl acrylate, styrene/butadiene/alkyl methacrylate, styrene/maleic anhy- dride, styrene/acrylonitrile/methyl acrylate; mixtures of high impact strength of styrene copolymers and another polymer, for example a polyacrylate, a diene polymer or an ethylene/pro- pylene/diene terpolymer; and block copolymers of styrene such as styrene/butadiene/sty- rene, styrene/isoprene/styrene, styrene/ethylene/butylene/styrene or styrene/ethylene/propy- lene/styrene.

6b. Hydrogenated aromatic polymers derived from hydrogenation of polymers mentioned under 6.), especially including polycyclohexylethylene (PCHE) prepared by hydrogenating atactic polystyrene, often referred to as polyvinylcyclohexane (PVCH).

6c. Hydrogenated aromatic polymers derived from hydrogenation of polymers mentioned under 6a.).

Homopolymers and copolymers may have any stereostructure including syndiotactic, isotactic, hemi-isotactic or atactic; where atactic polymers are preferred. Stereoblock polymers are also included.

7. Graft copolymers of vinyl aromatic monomers such as styrene or α-methylstyrene, for example styrene on polybutadiene, styrene on polybutadiene-styrene or polybutadiene-acry- lonitrile copolymers; styrene and acrylonitrile (or methacrylonitrile) on polybutadiene; styrene, acrylonitrile and methyl methacrylate on polybutadiene; styrene and maleic anhydride on polybutadiene; styrene, acrylonitrile and maleic anhydride or maleimide on polybutadiene; styrene and maleimide on polybutadiene; styrene and alkyl acrylates or methacrylates on polybutadiene; styrene and acrylonitrile on ethylene/propylene/diene terpolymers; styrene and acrylonitrile on polyalkyl acrylates or polyalkyl methacrylates, styrene and acrylonitrile on

acrylate/butadiene copolymers, as well as mixtures thereof with the copolymers listed under 6), for example the copolymer mixtures known as ABS, MBS, ASA or AES polymers.

8. Halogen-containing polymers such as polychloroprene, chlorinated rubbers, chlorinated and brominated copolymer of isobutylene-isoprene (halobutyl rubber), chlorinated or sulfo- chlorinated polyethylene, copolymers of ethylene and chlorinated ethylene, epichlorohydrin homo- and copolymers, especially polymers of halogen-containing vinyl compounds, for example polyvinyl chloride (PVC), polyvinylidene chloride, polyvinyl fluoride, polyvinylidene fluoride, as well as copolymers thereof such as vinyl chloride/vinylidene chloride, vinyl chloride/vinyl acetate or vinylidene chloride/vinyl acetate copolymers.

9. Polymers derived from α,β-unsatu rated acids and derivatives thereof such as polyacry- lates and polymethacrylates; polymethyl methacrylates, polyacrylamides and polyacryloni- triles, impact-modified with butyl acrylate.

10. Copolymers of the monomers mentioned under 9) with each other or with other unsaturated monomers, for example acrylonitrile/ butadiene copolymers, acrylonitrile/alkyl acrylate copolymers, acrylonitrile/alkoxyalkyl acrylate or acrylonitrile/vinyl halide copolymers or acrylonitrile/ alkyl methacrylate/butadiene terpolymers.

1 1. Polymers derived from unsaturated alcohols and amines or the acyl derivatives or ace- tals thereof, for example polyvinyl alcohol, polyvinyl acetate, polyvinyl stearate, polyvinyl benzoate, polyvinyl maleate, polyvinyl butyral, polyallyl phthalate or polyallyl melamine; as well as their copolymers with olefins mentioned in 1 ) above.

12. Homopolymers and copolymers of cyclic ethers such as polyalkylene glycols, polyethylene oxide, polypropylene oxide or copolymers thereof with bisglycidyl ethers.

13. Polyacetals such as polyoxymethylene and those polyoxymethylenes which contain ethylene oxide as a comonomer; polyacetals modified with thermoplastic polyurethanes, acrylates or MBS.

14. Polyphenylene oxides and sulfides, and mixtures of polyphenylene oxides with styrene polymers or polyamides.

15. Polyurethanes derived from hydroxyl-terminated polyethers, polyesters or polybutadi- enes on the one hand and aliphatic or aromatic polyisocyanates on the other, as well as precursors thereof.

16. Polyamides and copolyamides derived from diamines and dicarboxylic acids and/or from aminocarboxylic acids or the corresponding lactams (PA), for example polyamide 4, poly- amide 6, polyamide 6/6, 6/10, 6/9, 6/12, 4/6, 12/12, polyamide 1 1 , polyamide 12, aromatic polyamides starting from m-xylene diamine and adipic acid; polyamides prepared from hexamethylenediamine and isophthalic or/and terephthalic acid and with or without an elastomer as modifier, for example poly-2,4,4,-trimethylhexamethylene terephthalamide or poly-m-phenylene isophthalamide; and also block copolymers of the aforementioned polyamides with polyolefins, olefin copolymers, ionomers or chemically bonded or grafted elastomers; or with polyethers, e.g. with polyethylene glycol, polypropylene glycol or polytetramethylene glycol; as well as polyamides or copolyamides modified with EPDM or ABS; and polyamides condensed during processing (RIM polyamide systems).

17. Polyureas, polyimides, polyamide-imides, polyetherimids, polyesterimids, polyhydantoins and polybenzimidazoles.

18. Polyesters derived from dicarboxylic acids and diols and/or from hydroxycarboxylic acids or the corresponding lactones, for example polyethylene terephthalate (PET), polybutylene terephthalate, poly-1 ,4-dimethylolcyclohexane terephthalate, polyalkylene naphthalate (PAN) and polyhydroxybenzoates, polylactic acid (PLA), as well as block copolyether esters derived from hydroxyl-terminated polyethers; and also polyesters modified with polycarbonates or MBS.

19. Natural polymer naterials such as leather, cellulose, rubber, gelatin and chemically modified homologous derivatives thereof, for example cellulose acetates, cellulose propionates and cellulose butyrates, or the cellulose ethers such as methyl cellulose; as well as rosins and their derivatives.

20. Blends of the aforementioned polymers (polyblends), for example PP/EPDM, PoIy- amide/EPDM or ABS, PVC/EVA, PVC/ABS, PVC/MBS, PC/ABS, PBTP/ABS, PC/ASA,

PC/PBT, PVC/CPE, PVC/acrylates, POM/thermoplastic PUR, PC/thermoplastic PUR, POM/acrylate, POM/MBS, PPO/HIPS, PPO/PA 6.6 and copolymers, PA/HDPE, PA/PP, PA/PPO, PBT/PC/ABS or PBT/PET/PC.

Preferred substrates are polyethylene (PE) such as LDPE or HDPE; polypropylene (PP; homo or copolymer); ethylene vinylacetate (EVA); polyesters such as polyethylene terephthalate (PET), PET-G, polylactic acid (PLA), polytrimethylene terephthalate (PTT); polyol; polyoxymethylene (POM); thermoplastic polyolefin (TPO); polyurethane (PUR); thermoplastic polyurethane (TPU); polyvinyl chloride (PVC); polyamide (PA) such as PA 6 or PA 6.6; or corresponding blends. Most preferred are PP, PE, PET, PA, PUR, PLA, PTT.

Substrates often are in the form of fibers, fabrics, nonwovens, foams.

The materials, especially the polymer substrates, may also have incorporated therein one or more of the following known additives:

1. Antioxidants

1.1. Alkylated monophenols, for example 2,6-di-tert-butyl-4-methylphenol, 2-tert-butyl-4,6-di- methylphenol, 2,6-di-tert-butyl-4-ethylphenol, 2,6-di-tert-butyl-4-n-butylphenol, 2,6-di-tert-bu- tyl-4-isobutylphenol, 2,6-dicyclopentyl-4-methylphenol, 2-(α-methylcyclohexyl)-4,6-dimethyl- phenol, 2,6-dioctadecyl-4-methylphenol, 2,4,6-tricyclohexylphenol, 2,6-di-tert-butyl-4-meth- oxymethylphenol, nonylphenols which are linear or branched in the side chains, for example 2,6-di-nonyl-4-methylphenol, 2,4-dimethyl-6-(1 '-methylundec-1 '-yl)phenol, 2,4-dimethyl-6-(1 '- methylheptadec-1 '-yl)phenol, 2,4-dimethyl-6-(1'-methyltridec-1'-yl)phenol and mixtures thereof.

1.2. Alkylthiomethylphenols, for example 2,4-dioctylthiomethyl-6-tert-butylphenol, 2,4-dioctyl- thiomethyl-6-methylphenol, 2,4-dioctylthiomethyl-6-ethylphenol, 2,6-di-dodecylthiomethyl-4- nonylphenol.

1.3. Hydroquinones and alkylated hydroquinones, for example 2,6-di-tert-butyl-4-methoxy- phenol, 2,5-di-tert-butylhydroquinone, 2,5-di-tert-amylhydroquinone, 2,6-diphenyl-4-octade-

cyloxyphenol, 2,6-di-tert-butylhydroquinone, 2,5-di-tert-butyl-4-hydroxyanisole, 3,5-di-tert-bu- tyl-4-hydroxyanisole, 3,5-di-tert-butyl-4-hydroxyphenyl stearate, bis(3,5-di-tert-butyl-4-hy- droxyphenyl) adipate.

1.4. Tocopherols, for example α-tocopherol, β-tocopherol, γ-tocopherol, δ-tocopherol and mixtures thereof (vitamin E).

1.5. Hvdroxylated thiodiphenyl ethers, for example 2,2'-thiobis(6-tert-butyl-4-methylphenol), 2,2'-thiobis(4-octylphenol), 4,4'-thiobis(6-tert-butyl-3-methylphenol), 4,4'-thiobis(6-tert-butyl-2- methylphenol), 4,4'-thiobis(3,6-di-sec-amylphenol), 4,4'-bis(2,6-dimethyl-4-hydroxyphenyl)- disulfide.

1.6. Alkylidenebisphenols, for example 2,2'-methylenebis(6-tert-butyl-4-methylphenol), 2,2'- methylenebis(6-tert-butyl-4-ethylphenol), 2,2'-methylenebis[4-methyl-6-(α-methylcyclohexyl)- phenol], 2,2'-methylenebis(4-methyl-6-cyclohexylphenol), 2,2'-methylenebis(6-nonyl-4- methylphenol), 2,2'-methylenebis(4,6-di-tert-butylphenol), 2,2'-ethylidenebis(4,6-di-tert-bu- tylphenol), 2,2'-ethylidenebis(6-tert-butyl-4-isobutylphenol), 2,2'-methylenebis[6-(α-methyl- benzyl)-4-nonylphenol], 2,2'-methylenebis[6-(α,α-dimethylbenzyl)-4-nonylphenol], 4,4'- methylenebis(2,6-di-tert-butylphenol), 4,4'-methylenebis(6-tert-butyl-2-methylphenol), 1 ,1- bis(5-tert-butyl-4-hydroxy-2-methylphenyl)butane, 2,6-bis(3-tert-butyl-5-methyl-2-hydroxy- benzyl)-4-methylphenol, 1 , 1 ,3-tris(5-tert-butyl-4-hydroxy-2-methylphenyl)butane, 1 , 1 -bis(5- tert-butyl-4-hydroxy-2-methylphenyl)-3-n-dodecylmercaptobuta ne, ethylene glycol bis[3,3- bis(3'-tert-butyl-4'-hydroxyphenyl)butyrate], bis(3-tert-butyl-4-hydroxy-5-methyl-phenyl)di- cyclopentadiene, bis[2-(3'-tert-butyl-2'-hydroxy-5'-methylbenzyl)-6-tert-buty l-4-methylphe- nyl]terephthalate, 1 ,1-bis-(3,5-dimethyl-2-hydroxyphenyl)butane, 2,2-bis(3,5-di-tert-butyl-4- hydroxyphenyl)propane, 2,2-bis-(5-tert-butyl-4-hydroxy2-methylphenyl)-4-n-dodecylme rcap- tobutane, 1 ,1 ,5,5-tetra(5-tert-butyl-4-hydroxy-2-methylphenyl)pentane.

1.7. Q-, N- and S-benzyl compounds, for example 3,5,3',5'-tetra-tert-butyl-4,4'-dihydroxydi- benzyl ether, octadecyl-4-hydroxy-3,5-dimethylbenzylmercaptoacetate, tridecyl-4-hydroxy-

3,5-di-tert-butylbenzylmercaptoacetate, tris(3,5-di-tert-butyl-4-hydroxybenzyl)amine, bis(4- tert-butyl-3-hydroxy-2,6-dimethylbenzyl)dithioterephthalate, bis(3,5-di-tert-butyl-4-hydroxy- benzyl)sulfide, isooctyl-S^-di-tert-butyM-hydroxybenzylmercaptoacetate.

1.8. Hydroxybenzylated malonates, for example dioctadecyl-2,2-bis(3,5-di-tert-butyl-2-hy- droxybenzyl)malonate, di-octadecyl-2-(3-tert-butyl-4-hydroxy-5-methylbenzyl)malona te, di- dodecylmercaptoethyl-2,2-bis(3,5-di-tert-butyl-4-hydroxybenz yl)malonate, bis[4-(1 ,1 ,3,3-te- tramethylbutyl)phenyl]-2,2-bis(3,5-di-tert-butyl-4-hydroxybe nzyl)malonate.

1.9. Aromatic hydroxybenzyl compounds, for example 1 ,3,5-tris(3,5-di-tert-butyl-4-hydroxy- benzyl)-2,4,6-trimethylbenzene, 1 ,4-bis(3,5-di-tert-butyl-4-hydroxybenzyl)-2,3,5,6-tetrame- thylbenzene, 2,4,6-tris(3,5-di-tert-butyl-4-hydroxybenzyl)phenol.

1.10. Triazine compounds, for example 2,4-bis(octylmercapto)-6-(3,5-di-tert-butyl-4-hydroxy- anilino)-1 ,3,5-triazine, 2-octylmercapto-4,6-bis(3,5-di-tert-butyl-4-hydroxyanilino)- 1 ,3,5-tri- azine, 2-octylmercapto-4,6-bis(3,5-di-tert-butyl-4-hydroxyphenoxy)- 1 ,3,5-triazine, 2,4,6-tris- (3,5-di-tert-butyl-4-hydroxyphenoxy)-1 ,2,3-triazine, 1 ,3,5-tris(3,5-di-tert-butyl-4-hydroxyben- zyl)isocyanurate, 1 ,3,5-tris(4-tert-butyl-3-hydroxy-2,6-dimethylbenzyl)isocyanu rate, 2,4,6-tris- (3,5-di-tert-butyl-4-hydroxyphenylethyl)-1 ,3,5-triazine, 1 ,3,5-tris(3,5-di-tert-butyl-4-hydroxy- phenylpropionyl)-hexahydro-1 ,3,5-triazine, 1 ,3,5-tris(3,5-dicyclohexyl-4-hydroxybenzyl)iso- cyanurate.

1.1 1. Benzylphosphonat.es, for example dimethyl-2,5-di-tert-butyl-4-hydroxybenzylphospho- nate, diethyl-3,5-di-tert-butyl-4-hydroxybenzylphosphonate, dioctadecyl3,5-di-tert-butyl-4-hy- droxybenzylphosphonate, dioctadecyl-δ-tert-butyl^-hydroxy-S-methylbenzylphosphonate , the calcium salt of the monoethyl ester of 3,5-di-tert-butyl-4-hydroxybenzylphosphonic acid.

1.12. Acylaminophenols, for example 4-hydroxylauranilide, 4-hydroxystearanilide, octyl N- (3,5-di-tert-butyl-4-hydroxyphenyl)carbamate.

1.13. Esters of β-(3,5-di-tert-butyl-4-hvdroxyphenyl)propionic acid with mono- or polyhydric alcohols, e.g. with methanol, ethanol, n-octanol, i-octanol, octadecanol, 1 ,6-hexanediol, 1 ,9- nonanediol, ethylene glycol, 1 ,2-propanediol, neopentyl glycol, thiodiethylene glycol, diethy- lene glycol, triethylene glycol, pentaerythritol, tris(hydroxyethyl)isocyanurate, N,N'-bis(hy- droxyethyl)oxamide, 3-thiaundecanol, 3-thiapentadecanol, trimethylhexanediol, trimethylol- propane, 4-hydroxymethyl-1-phospha-2,6,7-trioxabicyclo[2.2.2]octane.

1.14. Esters of β-(5-tert-butyl-4-hvdroxy-3-methylphenyl)propionic acid with mono- or poly- hydric alcohols, e.g. with methanol, ethanol, n-octanol, i-octanol, octadecanol, 1 ,6-hexanedi- ol, 1 ,9-nonanediol, ethylene glycol, 1 ,2-propanediol, neopentyl glycol, thiodiethylene glycol, diethylene glycol, triethylene glycol, pentaerythritol, tris(hydroxyethyl)isocyanurate, N,N'-bis- (hydroxyethyl)oxamide, 3-thiaundecanol, 3-thiapentadecanol, trimethylhexanediol, trimethyl- olpropane, 4-hydroxymethyl-1 -phospha-2,6,7-trioxabicyclo[2.2.2]octane; 3,9-bis[2-{3-(3-tert- butyl-4-hydroxy-5-methylphenyl)propionyloxy}-1 ,1-dimethylethyl]-2,4,8,10-tetraoxaspiro[5.5]- undecane.

1.15. Esters of β-(3,5-dicvclohexyl-4-hvdroxyphenyl)propionic acid with mono- or polyhydric alcohols, e.g. with methanol, ethanol, octanol, octadecanol, 1 ,6-hexanediol, 1 ,9-nonanediol, ethylene glycol, 1 ,2-propanediol, neopentyl glycol, thiodiethylene glycol, diethylene glycol, triethylene glycol, pentaerythritol, tris(hydroxyethyl)isocyanurate, N,N'-bis(hydroxyethyl)ox- amide, 3-thiaundecanol, 3-thiapentadecanol, trimethylhexanediol, trimethylolpropane, 4-hy- droxymethyl-1 -phospha^θj-trioxabicyclop^^octane.

1.16. Esters of 3,5-di-tert-butyl-4-hvdroxyphenyl acetic acid with mono- or polyhydric alcohols, e.g. with methanol, ethanol, octanol, octadecanol, 1 ,6-hexanediol, 1 ,9-nonanediol, ethylene glycol, 1 ,2-propanediol, neopentyl glycol, thiodiethylene glycol, diethylene glycol, triethylene glycol, pentaerythritol, tris(hydroxyethyl)isocyanurate, N,N'-bis(hydroxyethyl)ox- amide, 3-thiaundecanol, 3-thiapentadecanol, trimethylhexanediol, trimethylolpropane, 4-hy- droxymethyl-1-phospha-2,6,7-trioxabicyclo[2.2.2]octane.

1.17. Amides of β-(3,5-di-tert-butyl-4-hvdroxyphenyl)propionic acid e.g. N,N'-bis(3,5-di-tert- butyl-4-hydroxyphenylpropionyl)hexamethylenediamide, N,N'-bis(3,5-di-tert-butyl-4-hydroxy- phenylpropionyl)trimethylenediamide, N,N'-bis(3,5-di-tert-butyl-4-hydroxyphenylpropionyl)hy- drazide, N,N'-bis[2-(3-[3,5-di-tert-butyl-4-hydroxyphenyl]propionylox y)ethyl]oxamide (Nau- gard ® XL-1 , supplied by Uniroyal).

1.18. Ascorbic acid (vitamin C)

1.19. Aminic antioxidants, for example N,N'-di-isopropyl-p-phenylenediamine, N,N'-di-sec- butyl-p-phenylenediamine, N,N'-bis(1 ,4-dimethylpentyl)-p-phenylenediamine, N,N'-bis(1- ethyl-3-methylpentyl)-p-phenylenediamine, N,N'-bis(1-methylheptyl)-p-phenylenediamine,

N,N'-dicyclohexyl-p-phenylenediamine, N,N'-diphenyl-p-phenylenediamine, N,N'-bis(2-naph- thyl)-p-phenylenediamine, N-isopropyl-N'-phenyl-p-phenylenediamine, N-(1 ,3-dimethylbutyl)- N'-phenyl-p-phenylenediamine, N-(1 -methylheptyl)-N'-phenyl-p-phenylenediamine, N- cyclohexyl-N'-phenyl-p-phenylenediamine, 4-(p-toluenesulfamoyl)diphenylamine, N,N'-di- methyl-N,N'-di-sec-butyl-p-phenylenediamine, diphenylamine, N-allyldiphenylamine, 4-iso- propoxydiphenylamine, N-phenyl-1 -naphthylamine, N-(4-tert-octylphenyl)-1 -naphthylamine, N-phenyl-2-naphthylamine, octylated diphenylamine, for example p,p'-di-tert-octyldiphenyl- amine, 4-n-butylaminophenol, 4-butyrylaminophenol, 4-nonanoylaminophenol, 4-dodeca- noylaminophenol, 4-octadecanoylaminophenol, bis(4-methoxyphenyl)amine, 2,6-di-tert-butyl- 4-dimethylaminomethylphenol, 2,4'-diaminodiphenylmethane, 4,4'-diaminodiphenylmethane, N,N,N',N'-tetramethyl-4,4'-diaminodiphenylmethane, 1 ,2-bis[(2-methylphenyl)amino]ethane, 1 ,2-bis(phenylamino)propane, (o-tolyl)biguanide, bis[4-(1 ',3'-dimethylbutyl)phenyl]amine, tert- octylated N-phenyl-1 -naphthylamine, a mixture of mono- and dialkylated tert-butyl/tert- octyldiphenylamines, a mixture of mono- and dialkylated nonyldiphenylamines, a mixture of mono- and dialkylated dodecyldiphenylamines, a mixture of mono- and dialkylated isopro- pyl/isohexyldiphenylamines, a mixture of mono- and dialkylated tert-butyldiphenylamines, 2,3-dihydro-3,3-dimethyl-4H-1 ,4-benzothiazine, phenothiazine, a mixture of mono- and dialkylated tert-butyl/tert-octylphenothiazines, a mixture of mono- and dialkylated tert-octylphe- nothiazines, N-allylphenothiazine, N,N,N',N'-tetraphenyl-1 ,4-diaminobut-2-ene.

2. UV absorbers and light stabilizers

2.1. 2-(2'-Hvdroxyphenyl)benzotriazoles, for example 2-(2'-hydroxy-5'-methylphenyl)benzo- triazole, 2-(3',5'-di-tert-butyl-2'-hydroxyphenyl)benzotriazole, 2-(5'-tert-butyl-2'-hydroxyphe- nyl)benzotriazole, 2-(2'-hydroxy-5'-(1 ,1 ,3,3-tetramethylbutyl)phenyl)benzotriazole, 2-(3',5'-di- tert-butyl-2'-hydroxyphenyl)-5-chlorobenzotriazole, 2-(3'-tert-butyl-2'-hydroxy-5'-methylphe- nyl)-5-chlorobenzotriazole, 2-(3'-sec-butyl-5'-tert-butyl-2'-hydroxyphenyl)benzotriazole , 2-(2'- hydroxy-4'-octyloxyphenyl)benzotriazole, 2-(3',5'-di-tert-amyl-2'-hydroxyphenyl)benzotriazole, 2-(3',5'-bis(α,α-dimethylbenzyl)-2'-hydroxyphenyl)benzotri azole, 2-(3'-tert-butyl-2'-hydroxy-5'- (2-octyloxycarbonylethyl)phenyl)-5-chlorobenzotriazole, 2-(3'-tert-butyl-5'-[2-(2-ethylhexyl- oxy)carbonylethyl]-2'-hydroxyphenyl)-5-chlorobenzotriazole, 2-(3'-tert-butyl-2'-hydroxy-5'-(2- methoxycarbonylethyl)phenyl)-5-chlorobenzotriazole, 2-(3'-tert-butyl-2'-hydroxy-5'-(2-meth- oxycarbonylethyl)phenyl)benzotriazole, 2-(3'-tert-butyl-2'-hydroxy-5'-(2-octyloxycarbonyl- ethyl)phenyl)benzotriazole, 2-(3'-tert-butyl-5'-[2-(2-ethylhexyloxy)carbonylethyl]-2'-hy droxy-

phenyl)benzotriazole, 2-(3'-dodecyl-2'-hydroxy-5'-methylphenyl)benzotriazole, 2-(3'-tert-butyl- 2'-hydroxy-5'-(2-isooctyloxycarbonylethyl)phenylbenzotriazol e, 2,2'-methylenebis[4-(1 ,1 ,3,3- tetramethylbutyl)-6-benzotriazole-2-ylphenol]; the transesterification product of 2-[3'-tert-bu- tyl-5'-(2-methoxycarbonylethyl)-2'-hydroxyphenyl]-2H-benzotr iazole with polyethylene glycol 300; [ R - CH 2 CH 2 - COO - CH 2 CH 2 -f- , where R = 3'-tert-butyl-4'-hydroxy-5'-2H-benzotriazol-

2-ylphenyl, 2-[2'-hydroxy-3'-(α,α-dimethylbenzyl)-5'-(1 ,1 ,3,3-tetramethylbutyl)- phenyl]benzotriazole; 2-[2'-hydroxy-3'-(1 ,1 ,3,3-tetramethylbutyl)-5'-(α,α-dimethylbenzyl)phe- nyl]benzotriazole.

2.2. 2-Hvdroxybenzophenones, for example the 4-hydroxy, 4-methoxy, 4-octyloxy, 4-decyl- oxy, 4-dodecyloxy, 4-benzyloxy, 4,2',4'-trihydroxy and 2'-hydroxy-4,4'-dimethoxy derivatives.

2.3. Esters of substituted and unsubstituted benzoic acids, for example 4-tert-butylphenyl salicylate, phenyl salicylate, octylphenyl salicylate, dibenzoyl resorcinol, bis(4-tert-butylben- zoyl)resorcinol, benzoyl resorcinol, 2,4-di-tert-butylphenyl 3,5-di-tert-butyl-4-hydroxybenzo- ate, hexadecyl 3,5-di-tert-butyl-4-hydroxybenzoate, octadecyl 3,5-di-tert-butyl-4-hydroxyben- zoate, 2-methyl-4,6-di-tert-butylphenyl 3,5-di-tert-butyl-4-hydroxybenzoate.

2.4. Acrylates, for example ethyl α-cyano-β,β-diphenylacrylate, isooctyl α-cyano-β,β-diphe- nylacrylate, methyl α-carbomethoxycinnamate, methyl α-cyano-β-methyl-p-methoxycinna- mate, butyl α-cyano-β-methyl-p-methoxycinnamate, methyl α-carbomethoxy-p-methoxycin- namate and N-(β-carbomethoxy-β-cyanovinyl)-2-methylindoline.

2.5. Nickel compounds, for example nickel complexes of 2,2'-thiobis[4-(1 ,1 ,3,3-tetramethyl- butyl)phenol], such as the 1 :1 or 1 :2 complex, with or without additional ligands such as n- butylamine, triethanolamine or N-cyclohexyldiethanolamine, nickel dibutyldithiocarbamate, nickel salts of the monoalkyl esters, e.g. the methyl or ethyl ester, of 4-hydroxy-3,5-di-tert- butylbenzylphosphonic acid, nickel complexes of ketoximes, e.g. of 2-hydroxy-4-methylphe- nylundecylketoxime, nickel complexes of 1-phenyl-4-lauroyl-5-hydroxypyrazole, with or with- out additional ligands.

2.6. Sterically hindered amines, for example bis(2,2,6,6-tetramethyl-4-piperidyl)sebacate, bis(2,2,6,6-tetramethyl-4-piperidyl)succinate, bis(1 ,2,2,6,6-pentamethyl-4-piperidyl)sebacate,

bis(1 -octyloxy-2,2,6,6-tetramethyl-4-piperidyl)sebacate, bis(1 ,2,2,6,6-pentamethyl-4-piperi- dyl) n-butyl-3,5-di-tert-butyl-4-hydroxybenzylmalonate, the condensate of 1-(2-hydroxyethyl)- 2,2,6,6-tetramethyl-4-hydroxypiperidine and succinic acid, linear or cyclic condensates of N,N'-bis(2,2,6,6-tetramethyl-4-piperidyl)hexamethylenediamin e and 4-tert-octylamino-2,6-di- chloro-1 ,3,5-triazine, tris(2,2,6,6-tetramethyl-4-piperidyl)nitrilotriacetate, tetrakis(2,2,6,6- tetramethyl-4-piperidyl)-1 ,2,3,4-butanetetracarboxylate, 1 ,1'-(1 ,2-ethanediyl)-bis(3, 3,5,5- tetramethylpiperazinone), 4-benzoyl-2,2,6,6-tetramethylpiperidine, 4-stearyloxy-2, 2,6,6- tetramethylpiperidine, bis(1 , 2,2,6, 6-pentamethylpiperidyl)-2-n-butyl-2-(2-hydroxy-3,5-di-tert- butylbenzyl)malonate, 3-n-octyl-7,7,9,9-tetramethyl-1 ,3,8-triazaspiro[4.5]decane-2,4-dione, bis(1 -octyloxy-2,2,6,6-tetramethylpiperidyl)sebacate, bis(1 -octyloxy^^θ.θ-tetramethylpipe- ridyl)succinate, linear or cyclic condensates of N,N'-bis(2,2,6,6-tetramethyl-4-piperidyl)hexa- methylenediamine and 4-morpholino-2,6-dichloro-1 ,3,5-triazine, the condensate of 2-chloro- 4,6-bis(4-n-butylamino-2,2,6,6-tetramethylpiperidyl)-1 ,3,5-triazine and 1 ,2-bis(3-aminopro- pylamino)ethane, the condensate of 2-chloro-4,6-di-(4-n-butylamino-1 , 2,2,6, 6-pentamethyl- piperidyl)-1 ,3,5-triazine and 1 ,2-bis(3-aminopropylamino)ethane, 8-acetyl-3-dodecyl-7, 7,9,9- tetramethyl-1 ,3,8-triazaspiro[4.5]decane-2,4-dione, 3-dodecyl-1 -(2,2,6,6-tetramethyl-4-pipe- ridyl)pyrrolidine-2,5-dione, 3-dodecyl-1 -(1 ,2,2,6,6-pentamethyl-4-piperidyl)pyrrolidine-2,5- dione, a mixture of 4-hexadecyloxy- and 4-stearyloxy-2,2,6,6-tetramethylpiperidine, a condensate of N,N'-bis(2,2,6,6-tetramethyl-4-piperidyl)hexamethylenediamin e and 4-cyclohexyl- amino-2,6-dichloro-1 ,3,5-triazine, a condensate of 1 ,2-bis(3-aminopropylamino)ethane and 2,4, 6-trichloro-1 ,3,5-triazine as well as 4-butylamino-2,2,6,6-tetramethylpiperidine (CAS Reg. No. [136504-96-6]); a condensate of 1 ,6-hexanediamine and 2, 4, 6-trichloro-1 ,3,5-triazine as well as N,N-dibutylamine and 4-butylamino-2,2,6,6-tetramethylpiperidine (CAS Reg. No. [192268-64-7]); N-(2,2,6,6-tetramethyl-4-piperidyl)-n-dodecylsuccinimide, N-(1 ,2,2,6,6- pentamethyl^-piperidyO-n-dodecylsuccinimide, 2-undecyl-7,7,9,9-tetramethyl-1 -oxa-3,8-di- aza-4-oxo-spiro[4,5]decane, a reaction product of 7,7,9,9-tetramethyl-2-cycloundecyl-1-oxa- 3,8-diaza-4-oxospiro-[4,5]decane and epichlorohydrin, 1 ,1-bis(1 , 2,2,6, 6-pentamethyl-4- piperidyloxycarbonyl)-2-(4-methoxyphenyl)ethene, N,N'-bis-formyl-N,N'-bis(2,2,6,6-tetrame- thyl-4-piperidyl)hexamethylenediamine, a diester of 4-methoxymethylenemalonic acid with 1 ,2,2,6,6-pentamethyl-4-hydroxypiperidine, poly[methylpropyl-3-oxy-4-(2,2,6,6-tetramethyl-4- piperidyl)]siloxane, a reaction product of maleic acid anhydride-α-olefin copolymer with 2,2,6,6-tetramethyl-4-aminopiperidine or 1 ,2,2,6,6-pentamethyl-4-aminopiperidine.

The sterically hindered amine may also be one of the compounds described in

GB-A-2 301 106 as component l-a), l-b), l-c), l-d), l-e), l-f), l-g), l-h), l-i), l-j), l-k) or l-l), in particular the light stabilizer 1-a-1 , 1-a-2, 1-b-1 , 1-C-1 , 1-C-2, 1-d-1 , 1-d-2, 1-d-3, 1-e-1 , 1 -f - 1 , 1-g-1 , 1-g-2 or 1-k-1 listed on pages 68 to 73 of said GB-A-2 301 106.

The sterically hindered amine may also be one of the compounds described in

EP-A-O 782 994, for example compounds as described in claims 10 or 38 or in Examples 1- 12 or D- 1 to D-5 therein.

2.7. Sterically hindered amines substituted on the N-atom by a hydroxy-substituted alkoxy group, for example compounds such as 1-(2-hydroxy-2-methylpropoxy)-4-octadecanoyloxy-

2,2,6,6-tetramethylpiperidine, 1-(2-hydroxy-2-methylpropoxy)-4-hexadecanoyloxy-2,2,6,6- tetramethylpiperidine, the reaction product of 1-oxyl-4-hydroxy-2,2,6,6-tetramethylpiperidine with a carbon radical from t-amylalcohol, 1-(2-hydroxy-2-methylpropoxy)-4-hydroxy-2, 2,6,6- tetramethylpiperidine, 1-(2-hydroxy-2-methylpropoxy)-4-oxo-2,2,6,6-tetramethylpiper idine, bis(1-(2-hydroxy-2-methylpropoxy)-2,2,6,6-tetramethylpiperid in-4-yl) sebacate, bis(1-(2- hydroxy-2-methylpropoxy)-2,2,6,6-tetramethylpiperidin-4-yl) adipate, bis(1 -(2-hydroxy-2- methylpropoxy)-2,2,6,6-tetramethylpiperidin-4-yl) succinate, bis(1 -(2-hydroxy-2-methylpro- poxy)-2,2,6,6-tetramethylpiperidin-4-yl) glutarate and 2,4-bis{N-[1-(2-hydroxy-2-methylpro- poxy)-2,2,6,6-tetramethylpiperidin-4-yl]-N-butylamino}-6-(2- hydroxyethylamino)-s-triazine.

2.8. Oxamides, for example 4,4'-dioctyloxyoxanilide, 2,2'-diethoxyoxanilide, 2,2'-dioctyloxy- 5,5'-di-tert-butoxanilide, 2,2'-didodecyloxy-5,5'-di-tert-butoxanilide, 2-ethoxy-2'-ethyloxanilide, N,N'-bis(3-dimethylaminopropyl)oxamide, 2-ethoxy-5-tert-butyl-2'-ethoxanilide and its mixture with 2-ethoxy-2'-ethyl-5,4'-di-tert-butoxanilide, mixtures of o- and p-methoxy-disubstituted oxanilides and mixtures of o- and p-ethoxy-disubstituted oxanilides.

2.9. 2-(2-Hydroxyphenyl)-1 ,3,5-triazines, for example 2,4,6-tris(2-hydroxy-4-octyloxyphenyl)- 1 ,3,5-triazine, 2-(2-hydroxy-4-octyloxyphenyl)-4,6-bis(2,4-dimethylphenyl)-1 ,3,5-triazine, 2- (2,4-dihydroxyphenyl)-4,6-bis(2,4-dimethylphenyl)-1 ,3,5-triazine, 2,4-bis(2-hydroxy-4-propyl- oxyphenyl)-6-(2,4-dimethylphenyl)-1 ,3,5-triazine, 2-(2-hydroxy-4-octyloxyphenyl)-4,6-bis(4- methylphenyl)-1 ,3,5-triazine, 2-(2-hydroxy-4-dodecyloxyphenyl)-4,6-bis(2,4-dimethylphenyl) - 1 ,3,5-triazine, 2-(2-hydroxy-4-tridecyloxyphenyl)-4,6-bis(2,4-dimethylphenyl )-1 ,3,5-triazine, 2- [2-hydroxy-4-(2-hydroxy-3-butyloxypropoxy)phenyl]-4,6-bis(2, 4-dimethyl)-1 ,3,5-triazine, 2-[2- hydroxy-4-(2-hydroxy-3-octyloxypropyloxy)phenyl]-4,6-bis(2,4 -dimethyl)-1 ,3,5-triazine, 2-[4-

(dodecyloxy/tridecyloxy-2-hydroxypropoxy)-2-hydroxyphenyl ]-4,6-bis(2,4-dimethylphenyl)- 1 ,3,5-triazine, 2-[2-hydroxy-4-(2-hydroxy-3-dodecyloxypropoxy)phenyl]-4,6-bi s(2,4-dimethyl- phenyl)-1 ,3,5-triazine, 2-(2-hydroxy-4-hexyloxy)phenyl-4,6-diphenyl-1 ,3,5-triazine, 2-(2-hy- droxy-4-methoxyphenyl)-4,6-diphenyl-1 ,3,5-triazine, 2,4,6-tris[2-hydroxy-4-(3-butoxy-2-hy- droxypropoxy)phenyl]-1 ,3,5-triazine, 2-(2-hydroxyphenyl)-4-(4-methoxyphenyl)-6-phenyl- 1 ,3,5-triazine, 2-{2-hydroxy-4-[3-(2-ethylhexyl-1-oxy)-2-hydroxypropyloxy]ph enyl}-4,6-bis(2,4- dimethylphenyl)-1 ,3,5-triazine.

3. Metal deactivators, for example N,N'-diphenyloxamide, N-salicylal-N'-salicyloyl hydrazine, N,N'-bis(salicyloyl)hydrazine, N,N'-bis(3,5-di-tert-butyl-4-hydroxyphenylpropionyl)hydrazin e, 3-salicyloylamino-1 ,2,4-triazole, bis(benzylidene)oxalyl dihydrazide, oxanilide, isophthaloyl dihydrazide, sebacoyl bisphenylhydrazide, N,N'-diacetyladipoyl dihydrazide, N,N'-bis(salicyl- oyl)oxalyl dihydrazide, N,N'-bis(salicyloyl)thiopropionyl dihydrazide.

4. Phosphites and phosphonites, for example triphenyl phosphite, diphenylalkyl phosphites, phenyldialkyl phosphites, tris(nonylphenyl) phosphite, trilauryl phosphite, trioctadecyl phosphite, distearylpentaerythritol diphosphite, tris(2,4-di-tert-butylphenyl) phosphite, diisodecyl pentaerythritol diphosphite, bis(2,4-di-tert-butylphenyl)pentaerythritol diphosphite, bis(2,4-di- cumylphenyl)pentaerythritol diphosphite, bis(2,6-di-tert-butyl-4-methylphenyl)pentaerythritol diphosphite, diisodecyloxypentaerythritol diphosphite, bis(2,4-di-tert-butyl-6-methylphenyl)- pentaerythritol diphosphite, bis(2,4,6-tris(tert-butylphenyl)pentaerythritol diphosphite, tristea- ryl sorbitol triphosphite, tetrakis(2,4-di-tert-butylphenyl) 4,4'-biphenylene diphosphonite, 6- isooctyloxy-2,4,8,10-tetra-tert-butyl-12H-dibenz[d,g]-1 ,3,2-dioxaphosphocin, bis(2,4-di-tert- butyl-6-methylphenyl)methyl phosphite, bis(2,4-di-tert-butyl-6-methylphenyl)ethyl phosphite, 6-fluoro-2,4,8,10-tetra-tert-butyl-12-methyl-dibenz[d,g]-1 ,3,2-dioxaphosphocin, 2,2',2"-nitrilo- [triethyltris(3,3',5,5'-tetra-tert-butyl-1 ,1 '-biphenyl-2,2'-diyl)phosphite], 2-ethylhexyl(3,3',5,5'-te- tra-tert-butyl-1 ,1 '-biphenyl-2,2'-diyl)phosphite, 5-butyl-5-ethyl-2-(2,4,6-tri-tert-butylphenoxy)- 1 ,3,2-dioxaphosphirane.

The following phosphites are especially preferred:

Tris(2,4-di-tert-butylphenyl) phosphite (lrgafos ® 168, Ciba Specialty Chemicals Inc.), tris(no- nylphenyl) phosphite,

— CH 2 CH(C 4 H 9 )CH 2 CH 3 (C)

(F) H 37 C 18 -O-P

5. Hydroxylamines, for example N,N-dibenzylhydroxylamine, N,N-diethylhydroxylamine, N, N- dioctylhydroxylamine, N,N-dilaurylhydroxylamine, N,N-ditetradecylhydroxylamine, N,N-di- hexadecylhydroxylamine, N,N-dioctadecylhydroxylamine, N-hexadecyl-N-octadecylhydroxyl- amine, N-heptadecyl-N-octadecylhydroxylamine, N,N-dialkylhydroxylamine derived from hydrogenated tallow amine.

6. Nitrones, for example N-benzyl-alpha-phenylnitrone, N-ethyl-alpha-methylnitrone, N-octyl- alpha-heptylnitrone, N-lauryl-alpha-undecylnitrone, N-tetradecyl-alpha-tridecylnitrone, N- hexadecyl-alpha-pentadecylnitrone, N-octadecyl-alpha-heptadecylnitrone, N-hexadecyl-al- pha-heptadecylnitrone, N-ocatadecyl-alpha-pentadecylnitrone, N-heptadecyl-alpha-hepta- decylnitrone, N-octadecyl-alpha-hexadecylnitrone, nitrone derived from N,N-dialkylhydroxyl- amine derived from hydrogenated tallow amine.

7. Amine oxides, for example amine oxide derivatives as disclosed in U.S. Patent Nos. 5,844,029 and 5,880,191 , didecyl methyl amine oxide, tridecyl amine oxide, tridodecyl amine oxide and trihexadecyl amine oxide.

8. Benzofuranones and indolinones, for example those disclosed in U.S. 4,325,863; U.S. 4,338,244; U.S. 5,175,312; U.S. 5,216,052; U.S. 5,252,643; DE-A-431661 1 ; DE-A-4316622; DE-A-4316876; EP-A-0589839 or EP-A-0591102 or 3-[4-(2-acetoxyethoxy)- phenyl]-5,7-di-tert-butylbenzofuran-2-one, 5,7-di-tert-butyl-3-[4-(2-stearoyloxyethoxy)phenyl]- benzofuran-2-one, 3,3'-bis[5,7-di-tert-butyl-3-(4-[2-hydroxyethoxy]phenyl)benz ofuran-2-one], 5,7-di-tert-butyl-3-(4-ethoxyphenyl)benzofuran-2-one, 3-(4-acetoxy-3,5-dimethylphenyl)-5,7- di-tert-butylbenzofuran-2-one, 3-(3,5-dimethyl-4-pivaloyloxyphenyl)-5,7-di-tert-butylbenzo- furan-2-one, 3-(3,4-dimethylphenyl)-5,7-di-tert-butylbenzofuran-2-one, 3-(2,3-dimethylphe- nyl)-5,7-di-tert-butylbenzofuran-2-one.

9. Thiosynergists, for example dilauryl thiodipropionate or distearyl thiodipropionate.

10. Peroxide scavengers, for example esters of β-thiodipropionic acid, for example the lauryl, stearyl, myristyl or tridecyl esters, mercaptobenzimidazole or the zinc salt of 2-mer- captobenzimidazole, zinc dibutyldithiocarbamate, dioctadecyl disulfide, pentaerythritol tetra- kis(β-dodecylmercapto)propionate.

1 1. Polyamide stabilizers, for example copper salts in combination with iodides and/or phosphorus compounds and salts of divalent manganese.

12. Basic co-stabilisers, for example melamine, polyvinylpyrrolidone, dicyandiamide, triallyl cyanurate, urea derivatives, hydrazine derivatives, amines, polyamides, polyurethanes, alkali metal salts and alkaline earth metal salts of higher fatty acids, for example calcium stearate, zinc stearate, magnesium behenate, magnesium stearate, sodium ricinoleate and potassium palmitate, antimony pyrocatecholate or zinc pyrocatecholate.

13. Nucleating agents, for example inorganic substances, such as talcum, metal oxides, such as titanium dioxide or magnesium oxide, phosphates, carbonates or sulfates of, preferably, alkaline earth metals; organic compounds, such as mono- or polycarboxylic acids and the salts thereof, e.g. 4-tert-butylbenzoic acid, adipic acid, diphenylacetic acid, sodium succinate or sodium benzoate; polymeric compounds, such as ionic copolymers (ionomers). Especially preferred are 1 ,3:2,4-bis(3',4'-dimethylbenzylidene)sorbitol, 1 ,3:2,4-di(paramethyl- dibenzylidene)sorbitol, and 1 ,3:2,4-di(benzylidene)sorbitol.

14. Fillers and reinforcing agents, for example calcium carbonate, silicates, glass fibres, glass bulbs, asbestos, talc, kaolin, mica, barium sulfate, metal oxides and hydroxides, carbon black, graphite, wood flour and flours or fibers of other natural products, synthetic fibers.

15. Other additives, for example plasticisers, lubricants, emulsifiers, pigments, dyes, rheolo- gy additives, catalysts, flow-control agents, optical brighteners, slip agents, crosslinking agents, crosslinking boosters, halogen scavengers, smoke inhibitors, flameproofing agents, antistatic agents, clarifiers such as substituted and unsubstituted bisbenzylidene sorbitols, benzoxazinone UV absorbers such as 2,2'-p-phenylene-bis(3,1-benzoxazin-4-one), Cya- sorb ® 3638 (CAS# 18600-59-4), and blowing agents.

16. Other biocides, for example fungicides such as 3,5-dimethyl-tetrahydro-1 ,3,5-2H-thio- diazin-2-thione, Bis-tributyltinoxide, 4.5-dichlor-2-n-octyl-4-isothiazolin-3-one, N-butyl-benz- isothiazoline, 10.10'-oxybisphenoxyarsine, zinc-2-pyridinthiol-1 -oxide, etc., and algicides such as 2-methylthio-4-cyclopropylamino-6-(α,β-dimethylpropylamino )-s-triazine, 2-methyl- thio-4-cyclopropylamino-6-tert-butylamino-s-triazine, 2-methylthio-4-ethylamino-6-(α,α-di- methylpropylamino)-s-triazine, etc.

These additives are often contained in amounts ranging from 0.01 to 10 % by weight of the material; usual amounts for these additional additives are ranging from about 0.05 to 5 % by weight. Fillers may be contained in higher amounts, e.g. 1-50% b.w.

Preferred additional additives are selected from the group consisting of antioxidants, ultraviolet light absorbers, hindered amines, phosphites or phosphonites, hydroxylamines, ni- trones, benzofuran-2-ones, thiosynergists, polyamide stabilizers, metal stearates, nucleating agents, fillers, reinforcing agents, lubricants, emulsifiers, dyes, pigments, optical brighteners, flame retardants, antistatic agents and blowing agents.

The acaricide agent(s) of the invention and optional further additives may be added to the plastic resin, e.g. the polyolefin, individually or mixed with one another. If desired, the individual components of an additive mixture can be mixed with one another in the melt (melt blending) before incorporation into the plastic material.

The acaricide agent(s) of the invention and optional further additives into the plastic material may be carried out by known methods such as dry mixing in the form of a powder, or wet mixing in the form of solutions or suspensions. The agent(s) and optional further additives may be incorporated, for example, before or after molding or also by applying the dissolved or dispersed additive to the plastic material, with or without subsequent evaporation of the solvent.

The acaricide agent(s) of the invention and optional further additives can also be added to the plastic material in the form of a masterbatch which contains these components in a concentration of about 1 to 80%, for example 2.5 % to 70 %, especially 5 % to 50 % by weight of the loaded carrier; in such operations, the polymer can be used in the form of powder, granules, solutions, suspensions or in the form of latices. The invention thus embraces a process for the production of an acaricide material, e.g. a fiber, fabric, foam, nonwoven, wherein the first agent and the optional second agent are incorporated into a thermoplastic polymer carrier in an amount ranging from 1 to 80% by weight of the carrier, and the loaded carrier is subsequently incorporated into the material, where both steps are carried out with application of heat.

If added to a plastic resin in the form of a masterbatch or concentrate, the present acaricide agent preferably is added via carriers such as LDPE, HDPE, MDPE, PP, EVA, ABS, SAN, PS, acrylates, PMMA, polyamide, polyesters, PVC, latex, styrene, polyol, PUR, TPU, unsaturated esters, urea, paraformaldehyde, water emulsion, etc.; especially preferred are LDPE, HDPE, PP, PA 6, PA 6.6, PET, PET-G (i.e. glycol-modified PET), PUR.

The present acaricide agent and optional further additives can also be added before, during or after polymerization or crosslinking.

The present acaricide agent and optional further additives can be incorporated into the plastic material in pure form or encapsulated in waxes, oils or polymers.

The present acaricide agent and optional further additives can also be sprayed onto the material. They are able to dilute other additives (for example the conventional additives in- icated above) or monomers or their melts so that they can be sprayed also together with these additives onto the material. Addition by spraying during the deactivation of the polymerization catalysts is particularly advantageous, it being possible to carry out spraying using, for example, the steam used for deactivation. In the case of spherically polymerized polyolefins it may, for example, be advantageous to apply the additives of the invention, optionally together with other additives, by spraying.

In general, the additives of the invention and optional further components may be added to the polymer material individually or mixed with one another. If desired, the individual components can be mixed with one another before incorporation into the polymer for example by dry blending, compaction or in the melt.

The incorporation of the additives of the invention and optional further components into the polymer is carried out by known methods such as dry blending in the form of a powder, or wet mixing in the form of solutions, dispersions or suspensions for example in an inert solvent, water or oil. The additives of the invention and optional further additives may be incorporated, for example, before or after molding or also by applying the dissolved or dispersed additve or additive mixture to the polymer material, with or without subsequent evaporation of the solvent or the suspension/dispersion agent. They may be added directly into the processing

apparatus (e.g. extruders, internal mixers, etc), e.g. as a dry mixture or powder or as solution or dispersion or suspension or melt.

The incorporation can be carried out in any heatable container equipped with a stirrer, e.g. in a closed apparatus such as a kneader, mixer or stirred vessel. The incorporation is preferably carried out in an extruder or in a kneader. It is immaterial whether processing takes place in an inert atmosphere or in the presence of oxygen.

The addition of the additive or additive blend to the polymer can be carried out in all customary mixing machines in which the polymer is melted and mixed with the additives. Suitable machines are known to those skilled in the art. They are predominantly mixers, kneaders and extruders.

Incorporation is preferably carried out in an extruder by introducing the additive during processing.

Particularly preferred processing machines are single-screw extruders, contrarotating and corotating twin-screw extruders, planetary-gear extruders, ring extruders or cokneaders. It is also possible to use processing machines provided with at least one gas removal compartment to which a vacuum can be applied.

Suitable extruders and kneaders are described, for example, in Handbuch der Kunststoffex- trusion, Vol. 1 Grundlagen, Editors F. Hensen, W. Knappe, H. Potente, 1989, pp. 3-7, ISBN:3-446-14339-4 (Vol. 2 Extrusionsanlagen 1986, ISBN 3-446-14329-7).

For example, the screw length is 1 - 60 screw diameters, preferably 35-48 screw diameters. The rotational speed of the screw is preferably 10 - 600 rotations per minute (rpm), very particularly preferably 25 - 300 rpm.

The maximum throughput is dependent on the screw diameter, the rotational speed and the driving force. The process of the present invention can also be carried out at a level lower than maximum throughput by varying the parameters mentioned or employing weighing machines delivering dosage amounts.

If a plurality of components are added, these can be premixed or added individually.

The polymer resins containing the additive(s)/agent(s) of the invention described herein can be used for the production inter alia of moldings, rotomolded articles, injection molded articles, blow molded articles, films, tapes, mono-filaments, fibers, nonwovens, foams, profiles, adhesives or putties, surface coatings and the like.

The articles containing the present anti-mite agent thus include synthetic fibers and fabrics including woven, nonwoven and knitted, as well as mattresses and foams. The effect of the invention is of particular interest in applications like filters, bed clothes including sheets, blankets mattress covers or pillowcases, upholstery fabrics or foams, textiles, and floor coverings including carpets, backing material like backing for flooring, underlay for carpets, textile back coating.

For the anti mite effect, the agent or agent combination according to the invention is incorporated into the polymer resin, which thereby becomes a reservoir for the controlled release of the agent over a long period of time. Mite populations are thus effectively reduced or removed on the surface of an article, in the bulk of an article containing hollow spaces, as well as in a fabric or pile, e.g. of a bedding, upholstery, mattress, garment, or carpet. Most preferred articles containing or consisting of the present anti-mite resin are fibers, foams or articles containing these fibers and/or foams including fabrics and nonwovens.

The following examples illustrate the invention in more detail. They are not to be construed as limiting the instant invention in any manner whatsoever. The invention is declared to cover all changes and modifications of the specific examples which do not constitute departure from the spirit and scope of the invention. All parts are given by weight unless specified otherwise; room temperature depicts a temperature in the range 20-25 0 C.

A) Processing conditions

1 ) Example with PP substrate:

Compounding: The agent is mixed with polypropylene pellets (Moplen HP 451 N, Albis Impex AG) at room temperature and extruded via a twin-screw extruder at 230 0 C. The molten polymer and agent exit via a round die and is immediately cooled and solidified in a cold- water through. The solidified strand is fed into a pelletizer.

Fiber spinning process: Continuous polypropylene multifilament fibers are prepared using a fiber spinning line under the following conditions: Extruder temperature of 24O 0 C, 40 filaments. Spinning pump speed is adjusted to produce fibers with a specific weight of 4.5 dpf. The fibers are then knitted to socks.

2) Example with PET substrate:

Compounding:

The agent(s) and the polyester pellets (RT 21 , Trevira GmbH) are dried at 120 0 C until a remaining humidity less than 50-100 ppm is reached. The agent is mixed with pellets at room temperature and extruded via a twin-screw extruder at 270 0 C. The molten polymer with agent exit via a round die and is immediately cooled and solidified in a cold-water through. The solidified strand is fed into a pelletizer.

Fiber spinning process:

The pellets are once again dried at 170 0 C until a rest of humidity lower than 50-100 ppm prior to spinning. Continuous polyester multifilament fibers are prepared using a fiber spinning line under the following conditions: Extruder temperature of 285 0 C, 40 filaments. Spinning pump speed is adjusted to produce fibers with a specific weight of 4.5 dpf. The fibers are then knitted to socks.

3) Example with polyamide PA6 substrate:

Compounding: The agent(s) and the polyamide pellets (Ultramid BS 400, BASF) are dried at 80°C until 500 ppm of rest of humidity is reached. The agent is mixed with pellets at room temperature and extruded via a twin-screw extruder at 260°C. The molten polymer with agent exit via a round die and is immediately cooled and solidified in a cold-water through. The solidified strand is fed into a pelletizer.

Fiber spinning process:

The pellets are once again dried at 80°C until 500 ppm of rest of humidity is reached prior to spinning. Continuous polyamide multifilament fibers are prepared using a fiber spinning line under the following conditions: Extruder temperature of 265 0 C, 40 filaments. Spinning pump speed is adjusted to produce fibers with a specific weight of 4.5 dpf. The fibers are then knitted to socks.

B) Testing

The knitted samples are evaluated on their anti-mite behavior. Experimental set-up: 10x10 cm samples are tested in triplicate for each formulation.

The samples are soiled with natural dust and acclimated to a specific humidity prior to inoculation with mites. To ensure the nutritional requirements of mites, skin scales and powdered yeast are added to the dust in the ratio of 3:1 :12 (w/w). Soiled units are placed on the bottom of a glass Petri dish (diameter 15 cm).

The different samples are then placed for one week into an incubator at specific mite optimal growth conditions (i.e. for the Dermatophagoides pteronyssinus species a temperature of 25°C and 75% relative humidity).

For comparison purposes, a textile sample of the same kind, but prepared without agent of the invention ("reference"), and an empty petri dish ("PCC bianco") are treated in the same way.

After acclimatization, each sample is inoculated with 50 mites (25 male and 25 female young adults) picked from a flourishing culture.

Incubation continues for 6 weeks after mite inoculation in order to allow the development of at least 2 generations of Dermatophagoides pteronyssinus under such optimal thermohydrogenic conditions.

C) Results

The results achieved with the polypropylene substrate (1 ) are summarized in Table 1 ; results achieved with the polyethyleneterephthalate substrate (2) are summarized in Table 2; results achieved with the polyamide substrate (3) are summarized in Table 3. Samples of the same polymer, but containing no anti-mite agent of the invention, serve as further comparison

Table 1 : Efficacy of anti-mite treatments applied on textile samples based on PP substrate.

Table 2: Efficacy of anti-mite treatments applied on textile samples based on PET substrate.

Table 3: Efficacy of anti-mite treatments applied on textile samples based on PA6 substrate.

* A qualitative observation is done after 2 and 4 weeks. Each sample receives a number from 0 to 3. Three marks are given to each sample, as there are 3 repetitions for each tested sample:

0 = no living dust mites observed 3 = considerable mite population development

** Quantitative measurements of mite population after 6 weeks of incubation at 25°C and 75% of relative humidity; number of alive mites on sample (average of 3 samples).

The results show that the present materials provide a distinct acaricide effect.